TissueGen to Feature ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MD&M East

23 May TissueGen to Feature ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MD&M East

WHO: TissueGen® Inc., developer of patented ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic, and medical device companies to develop fiber and textile medical devices for use in drug delivery applications such as small diameter vascular grafts and stents, tissue and nerve regeneration, orthopedic devices and sutures.

WHAT:  TissueGen will be exhibiting ELUTE fiber in booth 2003 at MD&M East.  Executives will be on hand to discuss how ELUTE fiber advances the state-of-the-art for controlled sustained delivery of biologics and pharmaceuticals. TissueGen’s patented manufacturing process occurs at room temperature, enabling the widest range of sensitive biologics and pharmaceuticals ever possible to be delivered from biodegradable implantable devices. By overcoming the challenges traditionally associated with melt extrusion, ELUTE fiber is ideally suited for a broad range of clinical applications and enables drug delivery from implantable devices for many therapeutic indications.

To learn how ELUTE fiber enables the next generation of medical device breakthroughs across a broad range of medical applications, please contact Christopher Knowles at cknowles@tissuegen.com or 1.214.351.1922 to set up a meeting.

WHERE:
MD&M East
Booth 2003
Javits Convention Center
New York, NY

WHEN: MD&M East will take place from June 12-14, 2018.

To schedule a briefing, please contact Sage Morander at sage.morander@svmpr.com or 1.401.490.9700.

About TissueGen

TissueGen® Inc. is the developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen has extensive experience in extruding biodegradable polymer fibers with broad drug delivery capabilities. ELUTE fiber can directly replace standard fibers used in biodegradable textiles currently on the market and provide significantly improved clinical outcomes by delivering therapeutic agents directly at the site of the implant.  By delivering drugs and growth factors at the site of implantation, ELUTE fiber enables medical devices to guide the body’s healing and regenerative processes. For more information, please visit www.tissuegen.com.

# # #

For more information contact:

Sage Morander
SVM Public Relations
1.401.490.9700
sage.morander@svmpr.com

No Comments

Sorry, the comment form is closed at this time.